Atezolizumab And Bevacizumab (Atezo + Bev) +- Radiotherapy (Rt) Vs Docetaxel (Doc) In Checkpoint Inhibitor (Cpi)-Experienced Metastatic Nsclc (Mnsclc): Results From The Phase Ib/Ii Morpheus-Lung Study
Atezolizumab;Bevacizumab;Docetaxel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Atezolizumab And Bevacizumab (Atezo + Bev) +- Radiotherapy (Rt) Vs Docetaxel (Doc) In Checkpoint Inhibitor (Cpi)-Experienced Metastatic Nsclc (Mnsclc): Results From The Phase Ib/Ii Morpheus-Lung Study ### Output: Atezolizumab;Bevacizumab;Docetaxel